- Business Wire•22 hours ago
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced that the company will host an Investor Day on Wednesday, March 1, 2017, in New York City.
- Zacks•7 days ago
TherapeuticsMD, Inc. (TXMD) announced the publication of two manuscripts detailing with the results of the company's pivotal phase III study (Rejoice) in Menopause: The Journal of The North American Menopause Society.
- Business Wire•9 days agoTherapeuticsMD Announces Publication of Two Manuscripts on the Rejoice Trial for TX-004HR in Leading Peer-Reviewed Medical Journal
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced the publication of two manuscripts detailing results of the company’s phase 3 Rejoice Trial in Menopause: The Journal of The North American Menopause Society, a widely-regarded forum for scholarly articles on the leading research related to menopause.
TXMD : Summary for TherapeuticsMD, Inc. Common Sto - Yahoo Finance
TherapeuticsMD, Inc. (TXMD)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Day's Range||5.57 - 5.88|
|52 Week Range||4.39 - 9.29|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-12.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|